Who owns IKT?
Institutional ownership of Inhibikase Therapeutics Inc. from Form 13F, Q2 2026
106 institutional managers reported holding Inhibikase Therapeutics Inc. (IKT) in Form 13F filings for Q2 2026, with 124,381,626 shares worth $252M. The largest reported holder was Sands Capital Alternatives, LLC. Managers that filed both quarters added a net 6,591,232 shares (+5.6%). 19 opened new positions and 14 sold out.
- Funds holding
- 106
- Value held
- $252M
- New / sold out
- 19 / 14
- Net shares, same filers
- +5.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IKT
Share of 13F holdings is each fund's shares as a share of the 124,381,626 IKT shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Nantahala Capital Management, LLC Added+$5.5M
- BlackRock, Inc. Added+$3.0M
- Kalehua Capital Management LLC Added+$2.3M
- Millennium Management LLC Added+$2.2M
- Trails Edge Capital Partners, LP Added+$2.0M
- ADAR1 Capital Management, LLC Added+$1.6M
- Sphera Funds Management LTD. New+$1.3M
- Kennondale Capital Management LLC New+$1.1M
- Pathstone Holdings, LLC New+$1.0M
- Vanguard Capital Management LLC Added+$984K
Biggest sellers in Q2 2026
- Perceptive Advisors LLC Sold out-$3.9M
- Ally Bridge Group (NY) LLC Sold out-$2.2M
- Citadel Advisors LLC Trimmed-$2.1M
- Stonepine Capital Management, LLC Trimmed-$1.1M
- Squadron Capital Management LLC Trimmed-$1.0M
- Bank of America Corp Trimmed-$436K
- Algert Global LLC Sold out-$225K
- Goldman Sachs Group Inc Trimmed-$202K
- Morgan Stanley Trimmed-$102K
- Nuveen, LLC Trimmed-$95K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $26.7M and sold $12.0M; 49 added and 23 trimmed.
Schedule 13D and 13G filings on IKT
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-28BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-07-17RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by Inhibikase Therapeutics Inc.Schedule 13G
- 2025-02-14Nantahala Capital Management, LLC SCHEDULE 13G filed by Inhibikase Therapeutics Inc.Schedule 13G
Questions about IKT ownership
- Who owns IKT stock?
- 106 institutional investment managers reported IKT positions in their Form 13F filings for Q2 2026, holding 124,381,626 shares worth $252M in total. Sands Capital Alternatives, LLC reported the largest position.
- Are funds buying or selling IKT?
- In Q2 2026, 19 managers opened new IKT positions, 49 added, 23 trimmed and 14 sold out. Managers that filed in both quarters added a net 6,591,232 shares.
- How current is this IKT institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IKT by CUSIP. Options are left out. IKT news and filings · IKT insider trades · Top funds